Endotoxin-lipoprotein hypothesis.
Mohrschladt
M F
MF
Smelt
A H
AH
Westendorp
R G
RG
D000069059:Atorvastatin; D008078:Cholesterol, LDL / Q000097:blood*; D006538:Heptanoic Acids / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006938:Hyperlipoproteinemia Type II / Q000097:blood* / Q000188:drug therapy*; D016753:Interleukin-10 / Q000097:blood; D008070:Lipopolysaccharides / Q000097:blood*; D011758:Pyrroles / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis*
D008078:Cholesterol, LDL; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008070:Lipopolysaccharides; D011758:Pyrroles; D014409:Tumor Necrosis Factor-alpha; D016753:Interleukin-10; D000069059:Atorvastatin